查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1615378

胃腸道糞便檢驗市場：按產品、測試、應用和最終用途 - 2025-2030 年全球預測

GI Stool Testing Market by Product (Analyzers, Consumables), Test (Bacteria Test, Fecal Biomarkers Test, Occult Blood Test), Application, End-use - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年，胃腸道糞便檢驗市值為6.5169億美元，預計到2024年將達到6.9183億美元，複合年成長率為6.67%，到2030年將達到10.2426億美元。

GI（胃腸道）糞便檢驗是胃腸道疾病（包括感染疾病、發炎性疾病和癌症篩檢）診斷和管理的重要組成部分。胃腸道糞便檢驗的範圍包括旨在檢測糞便樣本中的病原體、血液和其他異常情況的各種測試，提供非侵入性診斷選擇。此測試對於疾病的早期發現和管理至關重要，有助於改善患者預後和最佳治療策略。在應用方面，胃腸道糞便檢驗廣泛應用於醫院、診斷實驗室和家庭檢測場景等臨床環境。最終用戶主要是醫療保健提供者、患者和研究機構。市場洞察預測，由於胃腸道疾病盛行率不斷上升、早期篩檢意識不斷增強、考慮到便利性和隱私性的家庭檢測套組的採用等，預計將出現強勁的成長軌跡。分子診斷和多目標糞便 DNA 檢測等檢測方法的技術進步是主要的成長要素，為快速、準確的診斷提供了新的可能性。個人化醫療和遠端醫療的進步實現了遠距分析並增強了患者參與度，進一步增強了這個市場機會。儘管前景樂觀，但先進測試成本上升、資源匱乏地區的准入有限以及監管障礙等挑戰構成了重大障礙。為了克服這些障礙，市場相關人員應專注於創新，特別是在具有成本效益、快速且易於使用的測試解決方案方面，並在全球範圍內擴大意識計劃。透過人工智慧和機器學習提高測試靈敏度和特異性的研究和開發是一個利潤豐厚的探索領域。了解數位健康整合和預防性醫療保健策略等趨勢可以為您帶來市場優勢。當相關人員將其目標與新的成長軌跡和技術變革相結合時，了解市場的動態性質及其機會和挑戰至關重要。

主要市場統計
基準年[2023] 65169萬美元
預計年份 [2024] 69183萬美元
預測年份 [2030] 1,024,260,000 美元
複合年成長率（%） 6.67%

市場動態：揭示快速發展的胃腸道糞便檢驗市場的關鍵市場洞察

供需的動態交互作用正在改變胃腸道糞便檢驗市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助消費行為及其對製造業的影響。

  • 市場促進因素
    • 世界各地胃腸道疾病和疾病的增加
    • 政府和基金會努力提高胃腸健康意識
  • 市場限制因素
    • 胃腸道糞便檢驗中與產品召回相關的問題
  • 市場機會
    • 胃腸道糞便檢驗的技術進步可開發更準確、侵入性更小的工具
    • 醫療衛生政策改革及支持措施
  • 市場挑戰
    • 產品標準化和相容性挑戰

波特五力：駕馭胃腸道糞便檢驗市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解胃腸道糞便檢驗市場的外部影響

外部宏觀環境因素在塑造胃腸道糞便檢驗市場的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解胃腸道糞便檢驗市場的競爭狀況

胃腸道糞便檢驗市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來發現自己的競爭定位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣GI糞便檢驗市場供應商績效評估

FPNV定位矩陣是評估胃腸道糞便檢驗市場供應商的關鍵工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議，繪製胃腸道糞便檢驗市場的成功之路

對於想要加強在全球市場的影響力的公司來說，對胃腸道糞便檢驗市場進行策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 全球胃腸道疾病的發生率正在增加
      • 政府和基金會努力意識提升
    • 抑制因素
      • 與胃腸道糞便檢驗產品召回相關的問題
    • 機會
      • 胃腸道糞便檢驗方法的技術進步可開發更準確、侵入性更小的工具
      • 醫療衛生政策改革及支持措施
    • 任務
      • 產品標準化和相容性挑戰
  • 市場區隔分析
    • 產品：胃腸糞便分析儀因診斷速度快、準確度高而成為首選
    • 最終使用者：擴大胃腸道糞便檢驗在診斷中心的應用
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 胃腸道糞便檢驗市場：依產品

  • 分析儀
  • 消耗品

第7章 胃腸道糞便檢驗市場按測試

  • 細菌測試
  • 糞便生物標記檢測
    • 轉鐵蛋白測定
    • 腫瘤M2-PK糞便檢驗
  • 潛血檢查
    • 癒創木脂 FOB糞便檢驗
    • 免疫FOB凝集試驗
    • 免疫 FOB ELISA 測試
    • 側流免疫FOB測試
  • 卵子和寄生蟲測試

第8章 胃腸道糞便檢驗市場：依應用分類

  • 癌症
  • 胃食道逆流症
  • 感染
  • 發炎性腸道疾病

第9章 胃腸道糞便檢驗市場：依最終用途分類

  • 診斷中心
  • 家庭護理設置
  • 醫院/診所

第10章 北美和南美胃腸道糞便檢驗市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太胃腸道糞便檢驗市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章 歐洲、中東和非洲胃腸道糞便檢驗市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • ColoSense，非侵入性大腸直腸癌檢測的突破，獲得 FDA核准
    • 對 ColoTest 的評估，這是一種用於早期檢測胃腸道疾病的消費者友善家庭篩檢工具
    • Geneoscopy 與 LabCorp 合作增加了創新大腸直腸癌檢測的機會
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • Bio-Rad Laboratories, Inc.
  • bioMerieux SA
  • Cardinal Health
  • Cenogenics Corporation
  • CTK Biotech, Inc.
  • Danaher Corporation
  • Diagnostic Solutions Laboratory, LLC
  • DiaSorin SpA
  • Eiken Chemical Co., Ltd.
  • Emes Software, LLC
  • Epitope Diagnostics Inc.
  • Geisinger Medical Laboratories
  • Genova Diagnostics Inc.
  • Helena Laboratories Corporation
  • Hologic Inc.
  • Lauriston Laboratories Ltd
  • Meridian Bioscience Inc.
  • Pinnacle BioLabs
  • Polymedco, LLC
  • Quest Diagnostics
  • QuidelOrtho Corporation
  • ScheBo Biotech AG
  • Siemens Healthineers
Product Code: MRR-CB04E056547A

The GI Stool Testing Market was valued at USD 651.69 million in 2023, expected to reach USD 691.83 million in 2024, and is projected to grow at a CAGR of 6.67%, to USD 1,024.26 million by 2030.

GI (Gastrointestinal) stool testing is an essential component in diagnosing and managing gastrointestinal disorders, including infections, inflammatory diseases, and cancer screening. The scope of GI stool testing encompasses a range of tests designed to detect pathogens, blood, and other anomalies in stool samples, offering a non-invasive diagnostic option. This testing is crucial for early detection and management of diseases, contributing to better patient outcomes and optimal treatment strategies. Application-wise, GI stool testing has widespread use in clinical settings such as hospitals, diagnostics laboratories, and home-testing scenarios. End-users primarily include healthcare providers, patients, and research institutions. Market insights reveal a robust growth trajectory, driven by increasing prevalence of GI diseases, rising awareness about early screening, and the adoption of home-testing kits due to convenience and privacy. Technological advancements in testing methodologies, such as molecular diagnostics and multi-target stool DNA testing, are key growth influencers, presenting novel possibilities for rapid and accurate diagnosis. The evolving landscape of personalized medicine and telehealth further bolsters opportunities in this market, enabling remote analysis and enhanced patient engagement. Despite the positive outlook, challenges such as high costs of advanced testing, limited accessibility in low-resource regions, and regulatory hurdles pose significant roadblocks. Market players need to focus on innovation, especially in cost-effective, rapid, and user-friendly testing solutions, as well as expanding awareness programs worldwide to overcome these barriers. Research and development in enhancing sensitivity and specificity of tests through AI and machine learning present lucrative areas for exploration. Recognizing trends like digital health integration and preventive healthcare strategies can provide competitive market advantages. Understanding the dynamic nature of the market, with its mix of opportunities and challenges, is crucial for stakeholders to align their objectives with emerging growth trajectories and technological shifts.

KEY MARKET STATISTICS
Base Year [2023] USD 651.69 million
Estimated Year [2024] USD 691.83 million
Forecast Year [2030] USD 1,024.26 million
CAGR (%) 6.67%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving GI Stool Testing Market

The GI Stool Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising incidences of gastrointestinal disorders and diseases across the world
    • Efforts by governments and foundations to raise awareness for gastrointestinal health
  • Market Restraints
    • Issues associated with product recalls in GI stool testing
  • Market Opportunities
    • Technological advancements in GI stool testing methods to develop more accurate and less invasive tools
    • Reforms and supportive measures in healthcare policies
  • Market Challenges
    • Challenges with product standardization and compatibility

Porter's Five Forces: A Strategic Tool for Navigating the GI Stool Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the GI Stool Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the GI Stool Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the GI Stool Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the GI Stool Testing Market

A detailed market share analysis in the GI Stool Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the GI Stool Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the GI Stool Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the GI Stool Testing Market

A strategic analysis of the GI Stool Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the GI Stool Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Bio-Rad Laboratories, Inc., bioMerieux SA, Cardinal Health, Cenogenics Corporation, CTK Biotech, Inc., Danaher Corporation, Diagnostic Solutions Laboratory, LLC, DiaSorin S.p.A., Eiken Chemical Co., Ltd., Emes Software, LLC, Epitope Diagnostics Inc., Geisinger Medical Laboratories, Genova Diagnostics Inc., Helena Laboratories Corporation, Hologic Inc., Lauriston Laboratories Ltd, Meridian Bioscience Inc., Pinnacle BioLabs, Polymedco, LLC, Quest Diagnostics, QuidelOrtho Corporation, ScheBo Biotech AG, and Siemens Healthineers.

Market Segmentation & Coverage

This research report categorizes the GI Stool Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Analyzers and Consumables.
  • Based on Test, market is studied across Bacteria Test, Fecal Biomarkers Test, Occult Blood Test, and Ova and Parasites Test. The Fecal Biomarkers Test is further studied across Transferrin Assays and Tumor M2-PK Stool Test. The Occult Blood Test is further studied across Guaiac FOB Stool Test, Immuno FOB Agglutination Test, Immuno FOB ELISA Test, and Lateral Flow Immuno FOB Test.
  • Based on Application, market is studied across Cancer, Gastroesophageal Reflux Disease, Infection, and Inflammatory Bowel Disease.
  • Based on End-use, market is studied across Diagnostic Centers, Homecare Settings, and Hospitals & Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising incidences of gastrointestinal disorders and diseases across the world
      • 5.1.1.2. Efforts by governments and foundations to raise awareness for gastrointestinal health
    • 5.1.2. Restraints
      • 5.1.2.1. Issues associated with product recalls in GI stool testing
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in GI stool testing methods to develop more accurate and less invasive tools
      • 5.1.3.2. Reforms and supportive measures in healthcare policies
    • 5.1.4. Challenges
      • 5.1.4.1. Challenges with product standardization and compatibility
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Preference towards GI stool analyzers due to their speed and accuracy in diagnostics
    • 5.2.2. End-Users: Expanding application of GI Stool Testing in diagnostic centers
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. GI Stool Testing Market, by Product

  • 6.1. Introduction
  • 6.2. Analyzers
  • 6.3. Consumables

7. GI Stool Testing Market, by Test

  • 7.1. Introduction
  • 7.2. Bacteria Test
  • 7.3. Fecal Biomarkers Test
    • 7.3.1. Transferrin Assays
    • 7.3.2. Tumor M2-PK Stool Test
  • 7.4. Occult Blood Test
    • 7.4.1. Guaiac FOB Stool Test
    • 7.4.2. Immuno FOB Agglutination Test
    • 7.4.3. Immuno FOB ELISA Test
    • 7.4.4. Lateral Flow Immuno FOB Test
  • 7.5. Ova and Parasites Test

8. GI Stool Testing Market, by Application

  • 8.1. Introduction
  • 8.2. Cancer
  • 8.3. Gastroesophageal Reflux Disease
  • 8.4. Infection
  • 8.5. Inflammatory Bowel Disease

9. GI Stool Testing Market, by End-use

  • 9.1. Introduction
  • 9.2. Diagnostic Centers
  • 9.3. Homecare Settings
  • 9.4. Hospitals & Clinics

10. Americas GI Stool Testing Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific GI Stool Testing Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa GI Stool Testing Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. FDA Approval of ColoSense, A Breakthrough in Noninvasive Colorectal Cancer Screening
    • 13.3.2. Evaluation of ColoTest, A Consumer-Friendly, At-Home Screening Tool for Early Detection of Gastrointestinal Conditions
    • 13.3.3. Geneoscopy and Labcorp Partnership Elevates Access to Innovative Colorectal Cancer Screening
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Bio-Rad Laboratories, Inc.
  • 3. bioMerieux SA
  • 4. Cardinal Health
  • 5. Cenogenics Corporation
  • 6. CTK Biotech, Inc.
  • 7. Danaher Corporation
  • 8. Diagnostic Solutions Laboratory, LLC
  • 9. DiaSorin S.p.A.
  • 10. Eiken Chemical Co., Ltd.
  • 11. Emes Software, LLC
  • 12. Epitope Diagnostics Inc.
  • 13. Geisinger Medical Laboratories
  • 14. Genova Diagnostics Inc.
  • 15. Helena Laboratories Corporation
  • 16. Hologic Inc.
  • 17. Lauriston Laboratories Ltd
  • 18. Meridian Bioscience Inc.
  • 19. Pinnacle BioLabs
  • 20. Polymedco, LLC
  • 21. Quest Diagnostics
  • 22. QuidelOrtho Corporation
  • 23. ScheBo Biotech AG
  • 24. Siemens Healthineers

LIST OF FIGURES

  • FIGURE 1. GI STOOL TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. GI STOOL TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL GI STOOL TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL GI STOOL TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL GI STOOL TESTING MARKET SIZE, BY TEST, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL GI STOOL TESTING MARKET SIZE, BY TEST, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL GI STOOL TESTING MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL GI STOOL TESTING MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES GI STOOL TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES GI STOOL TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. GI STOOL TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. GI STOOL TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. GI STOOL TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL GI STOOL TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL GI STOOL TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. GI STOOL TESTING MARKET DYNAMICS
  • TABLE 7. GLOBAL GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL GI STOOL TESTING MARKET SIZE, BY ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL GI STOOL TESTING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL GI STOOL TESTING MARKET SIZE, BY BACTERIA TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL GI STOOL TESTING MARKET SIZE, BY TRANSFERRIN ASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL GI STOOL TESTING MARKET SIZE, BY TUMOR M2-PK STOOL TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL GI STOOL TESTING MARKET SIZE, BY GUAIAC FOB STOOL TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL GI STOOL TESTING MARKET SIZE, BY IMMUNO FOB AGGLUTINATION TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL GI STOOL TESTING MARKET SIZE, BY IMMUNO FOB ELISA TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL GI STOOL TESTING MARKET SIZE, BY LATERAL FLOW IMMUNO FOB TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL GI STOOL TESTING MARKET SIZE, BY OVA AND PARASITES TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL GI STOOL TESTING MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL GI STOOL TESTING MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL GI STOOL TESTING MARKET SIZE, BY INFECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL GI STOOL TESTING MARKET SIZE, BY INFLAMMATORY BOWEL DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL GI STOOL TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL GI STOOL TESTING MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL GI STOOL TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. CANADA GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
  • TABLE 55. CANADA GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. CANADA GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 57. MEXICO GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. MEXICO GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 59. MEXICO GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
  • TABLE 60. MEXICO GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
  • TABLE 61. MEXICO GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. MEXICO GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 63. UNITED STATES GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
  • TABLE 66. UNITED STATES GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
  • TABLE 67. UNITED STATES GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. UNITED STATES GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 69. UNITED STATES GI STOOL TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. AUSTRALIA GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 79. AUSTRALIA GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
  • TABLE 80. AUSTRALIA GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
  • TABLE 81. AUSTRALIA GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. AUSTRALIA GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 83. CHINA GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. CHINA GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 85. CHINA GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
  • TABLE 86. CHINA GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
  • TABLE 87. CHINA GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. CHINA GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 89. INDIA GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. INDIA GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 91. INDIA GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
  • TABLE 92. INDIA GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
  • TABLE 93. INDIA GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. INDIA GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 95. INDONESIA GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. INDONESIA GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 97. INDONESIA GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
  • TABLE 98. INDONESIA GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
  • TABLE 99. INDONESIA GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. INDONESIA GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 101. JAPAN GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. JAPAN GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 103. JAPAN GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
  • TABLE 104. JAPAN GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
  • TABLE 105. JAPAN GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. JAPAN GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 107. MALAYSIA GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. MALAYSIA GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 109. MALAYSIA GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
  • TABLE 110. MALAYSIA GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
  • TABLE 111. MALAYSIA GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. MALAYSIA GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 113. PHILIPPINES GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 114. PHILIPPINES GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 115. PHILIPPINES GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
  • TABLE 116. PHILIPPINES GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
  • TABLE 117. PHILIPPINES GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. PHILIPPINES GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 119. SINGAPORE GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. SINGAPORE GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 121. SINGAPORE GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
  • TABLE 122. SINGAPORE GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
  • TABLE 123. SINGAPORE GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. SINGAPORE GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH KOREA GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH KOREA GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH KOREA GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH KOREA GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH KOREA GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH KOREA GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 131. TAIWAN GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. TAIWAN GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 133. TAIWAN GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
  • TABLE 134. TAIWAN GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
  • TABLE 135. TAIWAN GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. TAIWAN GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 137. THAILAND GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. THAILAND GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 139. THAILAND GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
  • TABLE 140. THAILAND GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
  • TABLE 141. THAILAND GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. THAILAND GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 143. VIETNAM GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 144. VIETNAM GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 145. VIETNAM GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
  • TABLE 146. VIETNAM GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
  • TABLE 147. VIETNAM GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. VIETNAM GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 156. DENMARK GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 157. DENMARK GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 158. DENMARK GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
  • TABLE 159. DENMARK GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
  • TABLE 160. DENMARK GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 161. DENMARK GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 162. EGYPT GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 163. EGYPT GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 164. EGYPT GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
  • TABLE 165. EGYPT GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
  • TABLE 166. EGYPT GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. EGYPT GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 168. FINLAND GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 169. FINLAND GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 170. FINLAND GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
  • TABLE 171. FINLAND GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
  • TABLE 172. FINLAND GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 173. FINLAND GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 174. FRANCE GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 175. FRANCE GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 176. FRANCE GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
  • TABLE 177. FRANCE GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
  • TABLE 178. FRANCE GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. FRANCE GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 180. GERMANY GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 181. GERMANY GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 182. GERMANY GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
  • TABLE 183. GERMANY GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
  • TABLE 184. GERMANY GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 185. GERMANY GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 186. ISRAEL GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 187. ISRAEL GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 188. ISRAEL GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
  • TABLE 189. ISRAEL GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
  • TABLE 190. ISRAEL GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 191. ISRAEL GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 192. ITALY GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 193. ITALY GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 194. ITALY GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
  • TABLE 195. ITALY GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
  • TABLE 196. ITALY GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 197. ITALY GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 198. NETHERLANDS GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 199. NETHERLANDS GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 200. NETHERLANDS GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
  • TABLE 201. NETHERLANDS GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
  • TABLE 202. NETHERLANDS GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 203. NETHERLANDS GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 204. NIGERIA GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 205. NIGERIA GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 206. NIGERIA GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
  • TABLE 207. NIGERIA GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
  • TABLE 208. NIGERIA GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 209. NIGERIA GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 210. NORWAY GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 211. NORWAY GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 212. NORWAY GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
  • TABLE 213. NORWAY GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
  • TABLE 214. NORWAY GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 215. NORWAY GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 216. POLAND GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 217. POLAND GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 218. POLAND GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
  • TABLE 219. POLAND GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
  • TABLE 220. POLAND GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 221. POLAND GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 222. QATAR GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 223. QATAR GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 224. QATAR GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
  • TABLE 225. QATAR GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
  • TABLE 226. QATAR GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 227. QATAR GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 228. RUSSIA GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 229. RUSSIA GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 230. RUSSIA GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
  • TABLE 231. RUSSIA GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
  • TABLE 232. RUSSIA GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 233. RUSSIA GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 234. SAUDI ARABIA GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 235. SAUDI ARABIA GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 236. SAUDI ARABIA GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
  • TABLE 237. SAUDI ARABIA GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
  • TABLE 238. SAUDI ARABIA GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 239. SAUDI ARABIA GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 240. SOUTH AFRICA GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 241. SOUTH AFRICA GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 242. SOUTH AFRICA GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
  • TABLE 243. SOUTH AFRICA GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
  • TABLE 244. SOUTH AFRICA GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 245. SOUTH AFRICA GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 246. SPAIN GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 247. SPAIN GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 248. SPAIN GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
  • TABLE 249. SPAIN GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
  • TABLE 250. SPAIN GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 251. SPAIN GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 252. SWEDEN GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 253. SWEDEN GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 254. SWEDEN GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
  • TABLE 255. SWEDEN GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
  • TABLE 256. SWEDEN GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 257. SWEDEN GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 258. SWITZERLAND GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 259. SWITZERLAND GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 260. SWITZERLAND GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
  • TABLE 261. SWITZERLAND GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
  • TABLE 262. SWITZERLAND GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 263. SWITZERLAND GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 264. TURKEY GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 265. TURKEY GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 266. TURKEY GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
  • TABLE 267. TURKEY GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
  • TABLE 268. TURKEY GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 269. TURKEY GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 270. UNITED ARAB EMIRATES GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 271. UNITED ARAB EMIRATES GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 272. UNITED ARAB EMIRATES GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
  • TABLE 273. UNITED ARAB EMIRATES GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED ARAB EMIRATES GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED ARAB EMIRATES GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED KINGDOM GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED KINGDOM GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 278. UNITED KINGDOM GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
  • TABLE 279. UNITED KINGDOM GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
  • TABLE 280. UNITED KINGDOM GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 281. UNITED KINGDOM GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 282. GI STOOL TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 283. GI STOOL TESTING MARKET, FPNV POSITIONING MATRIX, 2023